These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1201186)

  • 1. Treatment of advanced bronchogenic carcinoma with adriamycin and 5-fluorouracil.
    Rees GJ; Bugaighis A; Anderson G
    Br J Dis Chest; 1975 Jul; 69():199-206. PubMed ID: 1201186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced bronchogenic carcinoma with adriamycin, 5-fluorouracil and methotrexate.
    Anderson G; Thomas G; Stewart-Jones J
    Br J Dis Chest; 1977 Jul; 71(3):179-82. PubMed ID: 302119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Status of adriamycin in cancer therapy].
    Berndt H
    Arch Geschwulstforsch; 1982; 52(7):585-96. PubMed ID: 7165492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of radiotherapy alone and radiotherapy with chemotherapy using adriamycin and 5-fluorouracil in bronchogenic carcinoma.
    Anderson G; Deeley TJ; Smith C; Jani J
    Thorax; 1981 Mar; 36(3):190-3. PubMed ID: 7281085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCNU-adriamycin therapy in bronchogenic carcinoma.
    Trowbridge RC; Kennedy BJ; Vosika GJ
    Cancer; 1978 May; 41(5):1704-9. PubMed ID: 206337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma.
    Alberto P; Barrelet L; Chapuis B; Garcia B
    Eur J Cancer (1965); 1975 Nov; 11(11):795-9. PubMed ID: 767111
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.
    Merrin C; Etra W; Wajsman Z; Baumgartner G; Murphy G
    J Urol; 1976 Jan; 115(1):86-8. PubMed ID: 1107604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adriamycin and adriamycin--DNA in inoperable bronchogenic carcinoma. A randomized study with cyclophosphamide vinblastine.
    Bosly A; Prignot J; Ledent C; Sokal G; Trouet A
    Eur J Cancer (1965); 1978 Jun; 14(6):639-44. PubMed ID: 658087
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiation plus 5-fluorouracil (NSC-19893): clinical demonstration of an additive effect in bronchogenic carcinoma.
    Cohen JL; Krant MJ; Shnider BI; Matias PI; Horton J; Baxter D
    Cancer Chemother Rep; 1971 Jun; 55(3):253-8. PubMed ID: 5115846
    [No Abstract]   [Full Text] [Related]  

  • 10. Sequential radiotherapy and adriamycin in the management of bronchogenic carcinoma: the question of additive toxicity.
    Ruckdeschel JC; Baxter DH; McKneally MF; Killam DA; Lunia SL; Horton J
    Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1323-8. PubMed ID: 528285
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
    Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
    Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination chemotherapy in patients with disseminated bronchogenic carcinoma (author's transl)].
    Gropp C; Havemann K; Gassel WD; Hess F; Prignitz R; Schmidt M; Sodomann CP
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1977 Dec; 90(3):301-6. PubMed ID: 146331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma.
    Collier D; Soloway MS
    Urology; 1976 Nov; 8(5):459-64. PubMed ID: 982733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
    Vogelzang NJ; Bonomi PD; Rossof AH; Wolter J
    Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-Fluorouracil (NSC-19893) compared to cyclophosphamide (NSC-26271) in bronchogenic carcinoma: results of a clinical study.
    Brugarolas A; Rivas A; Lacave AJ; Gonzalez-Palacois F; Froufe A
    Cancer Chemother Rep; 1975; 59(5):1025-6. PubMed ID: 1106844
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiotherapy plus 5-FU compared to radiotherapy alone for inoperable and unresectable bronchogenic carcinoma.
    Carr DT; Childs DS; Lee RE
    Cancer; 1972 Feb; 29(2):375-80. PubMed ID: 4622422
    [No Abstract]   [Full Text] [Related]  

  • 17. Adriamycin in advanced bronchogenic carcinoma.
    Cortes EP; Takita H; Holland JF
    Cancer; 1974 Sep; 34(3):518-25. PubMed ID: 4368383
    [No Abstract]   [Full Text] [Related]  

  • 18. Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.
    Eagan RT; Hahn RG; Myers RP
    Cancer Treat Rep; 1976 Jan; 60(1):115-7. PubMed ID: 1000515
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II study of doxorubicin and mitomycin in non-small cell bronchogenic carcinoma.
    Coates AS; Fox RM; Woods RL; Levi JA; Tattersall MH
    Cancer Treat Rep; 1982 Jan; 66(1):177-8. PubMed ID: 7053255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Polychemotherapy of bronchial carcinoma].
    Fazio M; Minetto E; Cavallero P; Sartoris S
    Minerva Med; 1970 Jun; 61(46):2567-70. PubMed ID: 5425737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.